Rationale for the combination therapy of 5FU and CDDP.
Saijo
N
N
Pharmacology Division, National Cancer Center Research Institute, Tokyo.
Sugirnoto
Y
Y
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004354:Drug Screening Assays, Antitumor; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014407:Tumor Cells, Cultured
D002945:Cisplatin; D005472:Fluorouracil